Dexmedetomidine for reducing succinylcholine-induced myalgia in patients undergoing electroconvulsive therapy: A randomised controlled trial
Background and Aim: Electroconvulsive therapy (ECT) is an effective intervention for psychiatric patients. Succinylcholine is considered the drug of choice for muscle relaxation for ECT. Significant adverse effects of succinylcholine include fasciculation and myalgia. Dexmedetomidine is a highly sel...
Збережено в:
| Автори: | , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Wolters Kluwer Medknow Publications
2024-05-01
|
| Серія: | Indian Journal of Anaesthesia |
| Предмети: | |
| Онлайн доступ: | https://journals.lww.com/10.4103/ija.ija_1159_23 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|